[Asia Economy Reporter Eunmo Koo] TegoScience announced on the 7th that it has acquired a patent related to compositions for the prevention and treatment of keloids or hypertrophic scars. The company explained the related patent as follows: "By providing biomarkers involved in the formation of collagen and cell proliferation that accumulate excessively during the scar healing process, it is possible to accurately diagnose abnormal scars such as hypertrophic scars, and to inhibit the formation of hypertrophic scars or keloids, making it applicable for treatment."



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing